SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Bone Biologics Corp – ‘8-K’ for 9/19/14 – ‘EX-3.1I’

On:  Thursday, 9/25/14, at 3:57pm ET   ·   For:  9/19/14   ·   Accession #:  1493152-14-3110   ·   File #:  0-53078

Previous ‘8-K’:  ‘8-K’ on 8/7/14 for 8/6/14   ·   Next:  ‘8-K’ on 10/30/14 for 10/24/14   ·   Latest:  ‘8-K’ on 3/15/24 for 3/12/24   ·   20 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 9/25/14  Bone Biologics Corp               8-K:1,2,3,5 9/19/14   79:9M                                     M2 Compliance/FA

Current Report   —   Form 8-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML    980K 
 2: EX-2.1      Plan of Acquisition, Reorganization, Arrangement,   HTML    433K 
                Liquidation or Succession                                        
 3: EX-2.2      Plan of Acquisition, Reorganization, Arrangement,   HTML     47K 
                Liquidation or Succession                                        
 4: EX-3.1I     Articles of Incorporation/Organization or Bylaws    HTML     28K 
 5: EX-3.1II    Articles of Incorporation/Organization or Bylaws    HTML     64K 
 6: EX-4.1      Instrument Defining the Rights of Security Holders  HTML     66K 
15: EX-4.10     Instrument Defining the Rights of Security Holders  HTML     84K 
16: EX-4.11     Instrument Defining the Rights of Security Holders  HTML     64K 
17: EX-4.12     Instrument Defining the Rights of Security Holders  HTML     85K 
18: EX-4.13     Instrument Defining the Rights of Security Holders  HTML     76K 
19: EX-4.14     Instrument Defining the Rights of Security Holders  HTML     75K 
20: EX-4.15     Instrument Defining the Rights of Security Holders  HTML     73K 
21: EX-4.16     Instrument Defining the Rights of Security Holders  HTML     73K 
22: EX-4.17     Instrument Defining the Rights of Security Holders  HTML     70K 
23: EX-4.18     Instrument Defining the Rights of Security Holders  HTML     74K 
24: EX-4.19     Instrument Defining the Rights of Security Holders  HTML    155K 
 7: EX-4.2      Instrument Defining the Rights of Security Holders  HTML     67K 
25: EX-4.20     Instrument Defining the Rights of Security Holders  HTML     85K 
26: EX-4.21     Instrument Defining the Rights of Security Holders  HTML     57K 
27: EX-4.22     Instrument Defining the Rights of Security Holders  HTML    136K 
28: EX-4.23     Instrument Defining the Rights of Security Holders  HTML     32K 
29: EX-4.24     Instrument Defining the Rights of Security Holders  HTML     38K 
30: EX-4.25     Instrument Defining the Rights of Security Holders  HTML     30K 
 8: EX-4.3      Instrument Defining the Rights of Security Holders  HTML     68K 
 9: EX-4.4      Instrument Defining the Rights of Security Holders  HTML     36K 
10: EX-4.5      Instrument Defining the Rights of Security Holders  HTML     70K 
11: EX-4.6      Instrument Defining the Rights of Security Holders  HTML     86K 
12: EX-4.7      Instrument Defining the Rights of Security Holders  HTML     82K 
13: EX-4.8      Instrument Defining the Rights of Security Holders  HTML     91K 
14: EX-4.9      Instrument Defining the Rights of Security Holders  HTML     84K 
31: EX-10.1     Material Contract                                   HTML     39K 
40: EX-10.10    Material Contract                                   HTML     58K 
41: EX-10.11    Material Contract                                   HTML     71K 
42: EX-10.12    Material Contract                                   HTML     57K 
43: EX-10.13    Material Contract                                   HTML     66K 
44: EX-10.14    Material Contract                                   HTML    236K 
45: EX-10.15    Material Contract                                   HTML     88K 
46: EX-10.16    Material Contract                                   HTML    215K 
47: EX-10.17    Material Contract                                   HTML     91K 
48: EX-10.18    Material Contract                                   HTML     90K 
32: EX-10.2     Material Contract                                   HTML    161K 
33: EX-10.3     Material Contract                                   HTML     48K 
34: EX-10.4     Material Contract                                   HTML     44K 
35: EX-10.5     Material Contract                                   HTML     44K 
36: EX-10.6     Material Contract                                   HTML     47K 
37: EX-10.7     Material Contract                                   HTML     47K 
38: EX-10.8     Material Contract                                   HTML     45K 
39: EX-10.9     Material Contract                                   HTML     57K 
49: EX-21.1     Subsidiaries List                                   HTML     20K 
66: R1          Document and Entity Information                     HTML     33K 
61: R2          Balance Sheets (Unaudited)                          HTML    166K 
64: R3          Balance Sheets (Unaudited) (Parenthetical)          HTML     47K 
68: R4          Statement of Operations (Unaudited)                 HTML     77K 
76: R5          Statements of Stockholders' Deficit                 HTML     90K 
62: R6          Statements of Stockholders' Deficit                 HTML     22K 
                (Parenthetical)                                                  
63: R7          Condensed Statements of Cash Flows (Unaudited)      HTML    109K 
60: R8          Basis of Presentation                               HTML     29K 
58: R9          The Company                                         HTML     37K 
77: R10         Summary of Significant Accounting Policies          HTML     49K 
70: R11         Accrued Expenses                                    HTML     38K 
69: R12         Commitments and Contingencies                       HTML     60K 
73: R13         Notes Payable to Related Party                      HTML     85K 
74: R14         Stockholders' Equity                                HTML    115K 
72: R15         Income Taxes                                        HTML     55K 
75: R16         Related Party Transactions                          HTML     32K 
65: R17         Subsequent Events                                   HTML     28K 
67: R18         Transaction                                         HTML     37K 
71: R19         Proforma Adjustments - Consolidated Statement of    HTML     47K 
                Financial Position                                               
79: R20         Proforma Adjustment - Statement of Operations       HTML     29K 
78: XML         IDEA XML File -- Filing Summary                      XML     63K 
56: EXCEL       IDEA Workbook of Financial Reports                  XLSX    113K 
59: EXCEL       IDEA Workbook of Financial Reports (.xls)            XLS    479K 
50: EX-101.INS  XBRL Instance -- boneb-20140630                      XML   1.02M 
52: EX-101.CAL  XBRL Calculations -- boneb-20140630_cal              XML     93K 
53: EX-101.DEF  XBRL Definitions -- boneb-20140630_def               XML    304K 
54: EX-101.LAB  XBRL Labels -- boneb-20140630_lab                    XML    353K 
55: EX-101.PRE  XBRL Presentations -- boneb-20140630_pre             XML    307K 
51: EX-101.SCH  XBRL Schema -- boneb-20140630                        XSD     73K 
57: ZIP         XBRL Zipped Folder -- 0001493152-14-003110-xbrl      Zip     77K 


‘EX-3.1I’   —   Articles of Incorporation/Organization or Bylaws


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



  EXHIBIT 3.1(i)  

 

AMENDED AND RESTATED CERTIFICATE OF INCORPORATION

 

OF

 

AFH ACQUISITION X, INC.

 

Pursuant to the provisions of Sections 242 and 245 of the Delaware General Corporation Law, the undersigned officer of AFH ACQUISITION X, INC. hereby executes this Amended and Restated Certificate of Incorporation (this “Amended and Restated Certificate of Incorporation”) to supersede its original Certificate of Incorporation filed with the Secretary of State of Delaware on October 18, 2007.

 

1. The name of the corporation is AFH ACQUISITION X, INC. (the “Corporation”).

 

2. The address of its registered office in the State of Delaware is 2711 Centerville Road, Suite 400, Wilmington, Delaware 19808, County of New Castle. The name of its registered agent at such address is the Corporation Service Company.

 

3. The nature of the business or purposes to be conducted or promoted is to engage in any lawful act or activity for which corporations may be organized under the General Corporation Law of Delaware (the “DGCL”).

 

4. The Corporation is to have perpetual existence.

 

5. The total number of shares of capital stock which the Corporation shall have authority to issue is: One Hundred Twenty Million (120,000,000). These shares shall be divided into two classes with 100,000,000 shares designated as common stock at $.001 par value (the “Common Stock”) and 20,000,000 shares designated as preferred stock at $.001 par value (the “Preferred Stock”).

 

The Preferred Stock of the Corporation shall be issued by the Board of Directors of the Corporation in one or more classes or one or more series within any class and such classes or series shall have such voting powers, full or limited, or no voting powers, and such designations, preferences, limitations or restrictions as the Board of Directors of the Corporation may determine, from time to time.

 

Holders of shares of Common Stock shall be entitled to cast one vote for each share held at all stockholders’ meetings for all purposes, including the election of directors. The Common Stock does not have cumulative voting rights.

 

No holder of shares of stock of any class shall be entitled as a matter of right to subscribe for or purchase or receive any part of any new or additional issue of shares of stock of any class, or of securities convertible into shares of stock of any class, whether now hereafter authorized or whether issued for money, for consideration other than money, or by way of dividend.

 

6. The Board of Directors shall have the power to adopt, amend or repeal the bylaws of the Corporation.

 

 C: 
 
 

 

7. No director shall be personally liable to the Corporation or its stockholders for monetary damages for any breach of fiduciary duty by such director as a director. Notwithstanding the foregoing sentence, a director shall be liable to the extent provided by applicable law, (i) for breach of the director’s duty of loyalty to the Corporation or its stockholders, (ii) for acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law, (iii) pursuant to Section 174 of the DGCL or (iv) for any transaction from which the director derived an improper personal benefit. If the DGCL hereafter is amended to authorize the further elimination or limitation of the liability of directors, then the liability of a director of the Corporation, in addition to the limitation on personal liability provided herein, shall be limited to the fullest extent permitted by the amended DGCL. No amendment to or repeal of this Article 7 shall apply to or have any effect on the liability or alleged liability of any director of the Corporation for or with respect to any acts or omissions of such director occurring prior to such amendment.

 

8. The Corporation shall indemnify, to the fullest extent permitted by Section 145 of the DGCL and the Corporation’s Bylaws, each as amended from time to time, each person that such section grants the Corporation the power to indemnify.

 

IN WITNESS WHEREOF, the Corporation has caused this Amended and Restated Certificate of Incorporation to be executed this 25th day of July, 2014.

 

  /s/ Amir F. Heshmatpour
  Amir F. Heshmatpour
  President, Secretary, Chief Financial Officer, and Sole Director


 

 C: 
-  C: 2 -
 

 


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘8-K’ Filing    Date    Other Filings
Filed on:9/25/14
For Period end:9/19/143,  4
10/18/07
 List all Filings 


20 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/26/24  Bone Biologics Corp.              S-1/A                  3:393K                                   M2 Compliance LLC/FA
 2/23/24  Bone Biologics Corp.              S-1/A                  7:1.3M                                   M2 Compliance LLC/FA
 2/21/24  Bone Biologics Corp.              10-K       12/31/23   63:6.3M                                   M2 Compliance LLC/FA
 1/30/24  Bone Biologics Corp.              S-1                   64:9.1M                                   M2 Compliance LLC/FA
11/20/23  Bone Biologics Corp.              10-K/A     12/31/22   14:425K                                   M2 Compliance LLC/FA
 9/15/23  Bone Biologics Corp.              S-8         9/15/23    4:121K                                   M2 Compliance LLC/FA
 6/13/23  Bone Biologics Corp.              S-1/A                  6:1M                                     M2 Compliance LLC/FA
 6/06/23  Bone Biologics Corp.              S-1/A                  6:1M                                     M2 Compliance LLC/FA
 5/01/23  Bone Biologics Corp.              S-1                    5:758K                                   M2 Compliance LLC/FA
 3/30/23  Bone Biologics Corp.              10-K       12/31/22   58:5.5M                                   M2 Compliance LLC/FA
10/05/22  Bone Biologics Corp.              S-1/A      10/04/22   59:8M                                     M2 Compliance LLC/FA
10/04/22  Bone Biologics Corp.              S-1/A                 59:8M                                     M2 Compliance LLC/FA
 9/23/22  Bone Biologics Corp.              S-1                   58:7.9M                                   M2 Compliance LLC/FA
 6/28/22  Bone Biologics Corp.              S-3                    5:1.1M                                   M2 Compliance LLC/FA
 3/15/22  Bone Biologics Corp.              10-K       12/31/21   59:5M                                     M2 Compliance LLC/FA
10/07/21  Bone Biologics Corp.              S-1/A                 60:9.2M                                   M2 Compliance LLC/FA
10/06/21  Bone Biologics Corp.              S-1/A                 59:8.2M                                   M2 Compliance LLC/FA
 8/30/21  Bone Biologics Corp.              S-1/A                 60:7.8M                                   M2 Compliance LLC/FA
 6/28/21  Bone Biologics Corp.              S-1                   71:5.9M                                   M2 Compliance LLC/FA
 4/15/21  Bone Biologics Corp.              10-K       12/31/20   63:4.3M                                   M2 Compliance LLC/FA
Top
Filing Submission 0001493152-14-003110   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., May 14, 7:01:18.2am ET